Saturday, April 4, 2026
Logo

Vertex Stock Pops On 'Remarkable' Results For Chronic Kidney Disease Drug

Vertex stock popped early Tuesday on promising results for a drug that could treat a chronic autoimmune disease that destroys the kidneys.

BusinessBy Robert KingsleyMarch 10, 20261 min read

Last updated: April 2, 2026, 2:49 AM

Share:
Vertex Stock Pops On 'Remarkable' Results For Chronic Kidney Disease Drug

Information in Investor’s Business Daily is for informational and educational purposes only and should not be construed as an offer, recommendation, solicitation, or rating to buy or sell securities. The information has been obtained from sources we believe to be reliable, but we make no guarantee as to its accuracy, timeliness, or suitability, including with respect to information that appears in closed captioning. Historical investment performances are no indication or guarantee of future success or performance. Authors/presenters may own the stocks they discuss. We make no representations or warranties regarding the advisability of investing in any particular securities or utilizing any specific investment strategies. Information is subject to change without notice. For information on use of our services, please see our Terms of Use.

*Real-time prices by Nasdaq Last Sale. Real-time quote and/or trade prices are not sourced from all markets. Ownership data provided by LSEG and Estimate data provided by FactSet.

IBD, IBD Digital, IBD Live, IBD Weekly, Investor's Business Daily, Leaderboard, MarketDiem, MarketSurge and other marks are trademarks owned by Investor's Business Daily, LLC.

©2026 Investor’s Business Daily, LLC. All Rights Reserved.

RK
Robert Kingsley

Business Editor

Robert Kingsley reports on markets, corporate news, and economic trends for the Journal American. With an MBA from Wharton and 15 years covering Wall Street, he brings deep expertise in financial markets and corporate strategy. His reporting on mergers and market movements is followed by investors nationwide.

Related Stories